Qiagen N v (QGEN)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
BioAegis Therapeutics Paves Path to ARDS Paradigm Shift with Revolutionary Gelsolin Study
QIAGEN*s Strong Q4 Performance and Positive Outlook Reflects Growth Potential in Non-COVID Portfolio
Kraken Robotics* AquaPix MINSAS System: A Game-Changer for Mine Countermeasure Operations
Headline: Qiagen N V Sees Significant Decrease in Revenue and Income in Fourth Quarter of 2023
Observing the fourth quarter of 2022 performance, the company*s made it had arduous period